ARDS Meeting Notes
The ARDS provides participants with a Meeting Notes PDF which includes most slide presentations from the meeting. The Meeting Notes are taken and assembled by talented and rising retinal stars. They attend every talk and capture the essence of the vigorous post-talk discussion, for which the ARDS is deservedly famous.
Please email ards@medconfs.com to request a copy of the Meeting Notes. Be sure to include the year(s) requested.
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
| Past ARDS Speakers “The list is huge. Many of us are very cognizant of the fact that we truly do stand on the shoulders of giants. In retina, many of the giants came regularly to that meeting. I remember very vividly being there with everyone from Tom Aaberg, Sr. to Steve Charles to Don Gass, many of the real luminaries in our field… Here was an opportunity to not only listen, but to stand up in front of your peers and probe into important clinical questions in a forum that not only permitted it, but encouraged it.” David Parke, II |
|
|---|---|
| Records per page: | |
| 2008 36th Annual Meeting | |
| Diana V. Do, MD | Does 25g Vitrectomy Increase the Risk for Endophthalmitis? |
| Diana V. Do, MD | Re-Treatment Decision Making for Choroidal Neovascularization: Comparison of OCT vs. Fluorescein |
| K.Bailey Freund, MD | Optimizing an Anti-VEGF Treatment Regimen in AMD: Does Maintenance Benefit the Fellow Eye? |
| K.Bailey Freund, MD | The Latest Rap on RAP: A Revised Classification for Choroidal Neovascularization |
| Allen C. Ho, MD | Dry Age-related Macular Degeneration: The Next Big Thing |
| Allen C. Ho, MD | Techniques and Tips for Microincision Vitrectomy Surgery 2008 |
| Allan E. Kreiger, MD | Scleral Buckling for Retinal Detachment |
| George A. Williams, MD | Retinal Neuroprotection: The Next Frontier |
| George A. Williams, MD | The Future of Physician Reimbursement |
| 2007 35th Annual Meeting | |
| Robert L. Avery, MD | Anti-VEGF Therapy in Complex Proliferative and Non-proliferative Diabetic Retinopathy |
| Robert L. Avery, MD | Anti-VEGF Therapy in Treatment of Vascular Occlusion — Avastin or Lucentis |
| Mark S. Blumenkranz, MD | Evolving Concepts of Retinal Photocoagulation |
| Dean Eliott, MD | Advanced Technology: Implications for Future Clinical Directions |
| Dean Eliott, MD | Update on Steroid Implants: Applications and Concerns |
| Harry W. Flynn, Jr., MD | Endophthalmitis: Recent Challenging Cases |
| Harry W. Flynn, Jr., MD | Evolving Strategies in Diabetic Retinopathy: Toward a Treatment Algorithm |
| Christine R. Gonzales, MD | 25 Gauge Vitrectomy for Pediatric Vitreoretinal Surgery |
| Christine R. Gonzales, MD | The PASCAL (Pattern Scanning Laser) Photocoagulator: Clinical Impressions |
| William F. Hoyt, MD | Neuro-ophthalmologic Retina 2007 |
| William F. Mieler, MD | Controversies in the Management of Open-Globe Injuries Involving the Posterior Segment |
| William F. Mieler, MD | Systemic Therapeutic Agents and Retinal Toxicity |
| Timothy G. Murray, MD, MBA | Implications of “Off-label” Therapy in Retinal Disease Management |
| Timothy G. Murray, MD, MBA | Ocular Oncology: Revisiting the Controversies |
| Masahito Ohji, MD | Surgical Treatments for CRVO: Still Useful? |
| Masahito Ohji, MD | Vitrectomy for Macular Hole: Long-term Visual Outcomes |
| PREV | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 | NEXT |
